Laboratorio Reig Jofre, S.A. (BME:RJF)
Spain · Delayed Price · Currency is EUR 2.710
+0.010 (0.37%)
Jun 5, 2026, 5:35 PM CET
Laboratorio Reig Jofre Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 5.02 | 10.38 | 9.41 | 8.11 | 5.09 |
Depreciation & Amortization | 21.22 | 19.93 | 19.85 | 17.48 | 14.86 |
Other Amortization | 3.57 | 3.43 | 3.3 | 3.59 | 3.19 |
Loss (Gain) From Sale of Assets | 1.17 | 1.38 | 0.72 | 0.57 | 0.44 |
Asset Writedown & Restructuring Costs | 0.63 | 1 | 1 | 0.4 | - |
Loss (Gain) on Equity Investments | 0.31 | 0.12 | -0.98 | -1.59 | -0.09 |
Provision & Write-off of Bad Debts | -0.6 | 0.36 | -0.15 | -0.07 | 0.06 |
Other Operating Activities | -15.48 | -1.75 | -2.43 | -9.06 | -2.03 |
Change in Accounts Receivable | -6.94 | -1.23 | -4.73 | -3.08 | -1.75 |
Change in Inventory | 2.53 | -2.07 | -13.91 | -1.06 | -7.11 |
Change in Accounts Payable | -9.91 | -0.25 | 6.85 | 0.86 | 1.85 |
Change in Other Net Operating Assets | - | 0.04 | 0.21 | - | - |
Operating Cash Flow | 1.51 | 31.34 | 19.12 | 16.15 | 14.5 |
Operating Cash Flow Growth | -95.17% | 63.95% | 18.38% | 11.38% | -21.94% |
Capital Expenditures | -15.29 | -20.26 | -12.46 | -10.95 | -19.23 |
Sale of Property, Plant & Equipment | - | - | - | 0.11 | 0.11 |
Cash Acquisitions | 1.05 | - | - | -2 | -15 |
Sale (Purchase) of Intangibles | -3.01 | -0.52 | -0.31 | -0.41 | -0.54 |
Investment in Securities | -0.56 | -11.18 | -0.11 | 0.52 | -0.05 |
Investing Cash Flow | -17.82 | -31.97 | -12.88 | -12.72 | -34.7 |
Long-Term Debt Issued | 32.49 | 32.88 | 10.22 | 15.31 | 29.46 |
Long-Term Debt Repaid | -23.9 | -28.43 | -17.98 | -17.33 | -15.16 |
Net Debt Issued (Repaid) | 8.59 | 4.45 | -7.77 | -2.02 | 14.3 |
Repurchase of Common Stock | - | - | -0.02 | -0.36 | -0.75 |
Common Dividends Paid | -0.03 | -0.03 | -0.04 | -0.05 | -0.06 |
Other Financing Activities | 7.76 | 1.16 | 0.67 | 0.39 | 0.18 |
Financing Cash Flow | 16.31 | 5.59 | -7.16 | -2.04 | 13.67 |
Net Cash Flow | 0.01 | 4.97 | -0.93 | 1.39 | -6.53 |
Free Cash Flow | -13.78 | 11.08 | 6.65 | 5.2 | -4.73 |
Free Cash Flow Growth | - | 66.51% | 27.90% | - | - |
Free Cash Flow Margin | -4.09% | 3.25% | 2.09% | 1.90% | -1.97% |
Free Cash Flow Per Share | -0.17 | 0.14 | 0.08 | 0.07 | -0.06 |
Cash Interest Paid | 1.62 | 1.96 | 1.23 | 1.04 | 0.88 |
Cash Income Tax Paid | -0.74 | -0.29 | 1.47 | 0.88 | 0.91 |
Levered Free Cash Flow | 11.18 | 4.16 | 4.58 | 8.98 | -18.25 |
Unlevered Free Cash Flow | 12.03 | 4.79 | 5.04 | 9.41 | -17.83 |
Change in Working Capital | -14.32 | -3.52 | -11.58 | -3.28 | -7.01 |